Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review

Venous thromboembolism (VTE) is associated with high recurrence, mortality, and cost burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they offer more benefits over warfarin, despite being more expensive. There is no consensus on the most cost-effective DOAC agent,...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Mukdad, Mohammad, Al-Badriyeh, Daoud, Elewa, Hazem Fathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714902/
https://www.ncbi.nlm.nih.gov/pubmed/31088296
http://dx.doi.org/10.1177/1076029619849103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714902/
https://www.ncbi.nlm.nih.gov/pubmed/31088296
http://dx.doi.org/10.1177/1076029619849103

Ejemplares similares